Your browser doesn't support javascript.
loading
SARS-CoV-2 Vaccine Alpha and Delta Variant Breakthrough Infections Are Rare and Mild but Can Happen Relatively Early after Vaccination.
Peter, Jelissa Katharina; Wegner, Fanny; Gsponer, Severin; Helfenstein, Fabrice; Roloff, Tim; Tarnutzer, Rahel; Grosheintz, Kerstin; Back, Moritz; Schaubhut, Carla; Wagner, Sabina; Seth-Smith, Helena M B; Scotton, Patrick; Redondo, Maurice; Beckmann, Christiane; Stadler, Tanja; Salzmann, Andrea; Kurth, Henriette; Leuzinger, Karoline; Bassetti, Stefano; Bingisser, Roland; Siegemund, Martin; Weisser, Maja; Battegay, Manuel; Sutter, Sarah Tschudin; Lebrand, Aitana; Hirsch, Hans H; Fuchs, Simon; Egli, Adrian.
Afiliación
  • Peter JK; Department of Health Basel-City, 4052 Basel, Switzerland.
  • Wegner F; Applied Microbiology Research, Department of Biomedicine, University of Basel, 4056 Basel, Switzerland.
  • Gsponer S; Division of Clinical Bacteriology and Mycology, University Hospital Basel, 4031 Basel, Switzerland.
  • Helfenstein F; SIB Swiss Institute of Bioinformatics, 1015 Lausanne, Switzerland.
  • Roloff T; Department of Health Basel-City, 4052 Basel, Switzerland.
  • Tarnutzer R; Department of Clinical Research, University Hospital Basel, 4031 Basel, Switzerland.
  • Grosheintz K; Applied Microbiology Research, Department of Biomedicine, University of Basel, 4056 Basel, Switzerland.
  • Back M; Division of Clinical Bacteriology and Mycology, University Hospital Basel, 4031 Basel, Switzerland.
  • Schaubhut C; SIB Swiss Institute of Bioinformatics, 1015 Lausanne, Switzerland.
  • Wagner S; Department of Health Basel-City, 4052 Basel, Switzerland.
  • Seth-Smith HMB; Department of Health Basel-City, 4052 Basel, Switzerland.
  • Scotton P; Department of Health Basel-City, 4052 Basel, Switzerland.
  • Redondo M; Department of Health Basel-City, 4052 Basel, Switzerland.
  • Beckmann C; Department of Health Basel-City, 4052 Basel, Switzerland.
  • Stadler T; Applied Microbiology Research, Department of Biomedicine, University of Basel, 4056 Basel, Switzerland.
  • Salzmann A; Division of Clinical Bacteriology and Mycology, University Hospital Basel, 4031 Basel, Switzerland.
  • Kurth H; SIB Swiss Institute of Bioinformatics, 1015 Lausanne, Switzerland.
  • Leuzinger K; Corona Vaccination Centre for the Canton of Basel-City, 4058 Basel, Switzerland.
  • Bassetti S; Viollier AG, 4123 Allschwil, Switzerland.
  • Bingisser R; Viollier AG, 4123 Allschwil, Switzerland.
  • Siegemund M; Department of Biosystems Science and Engineering, ETH Zurich, 4058 Basel, Switzerland.
  • Weisser M; Viollier AG, 4123 Allschwil, Switzerland.
  • Battegay M; Viollier AG, 4123 Allschwil, Switzerland.
  • Sutter ST; Clinical Virology, University Hospital Basel, 4031 Basel, Switzerland.
  • Lebrand A; Transplantation & Clinical Virology, Department of Biomedicine, University of Basel, 4056 Basel, Switzerland.
  • Hirsch HH; Internal Medicine, University Hospital Basel, 4031 Basel, Switzerland.
  • Fuchs S; Emergency Medicine, University Hospital Basel, 4031 Basel, Switzerland.
  • Egli A; Intensive Care Medicine, University Hospital Basel, 4031 Basel, Switzerland.
Microorganisms ; 10(5)2022 Apr 21.
Article en En | MEDLINE | ID: mdl-35630302
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Microorganisms Año: 2022 Tipo del documento: Article País de afiliación: Suiza
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Microorganisms Año: 2022 Tipo del documento: Article País de afiliación: Suiza